Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$498,962
+$116,338 QoQ
Shares Held
416
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#3,758
of 4,605 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roble, Belko & Company, Inc holds $3,192,754 across 12 Drug Manufacturers - General names. LLY ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,506 | $1,385,529 | |
| 2 | JNJ |
Johnson & Johnson
|
3,549 | $901,339 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
416 | $498,962 | |
| 4 | PFE |
Pfizer Inc
|
8,245 | $198,539 | |
| 5 | MRK |
Merck & Co., Inc.
|
478 | $61,423 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
919 | $52,952 | |
| 7 | GSK |
GSK plc
|
685 | $35,907 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
218 | $27,542 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,962 | 416 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $382,624 | 416 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $18,269 | 17 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $12,971 | 17 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2 | 2 | Shares | Sole | 2025-08-04 | |
| 2022-03-31 | $8,591 | 30 | Shares | Sole | 2022-05-06 | |
| No filing history on record for this holder in this stock. | ||||||